Skip to main content
Dr. Lal Pathlabs Limited logo

Dr. Lal Pathlabs Limited — Investor Relations & Filings

Ticker · LALPATHLAB ISIN · INE600L01024 LEI · 984500E8E9CY102B9718 BSE.NS Human health and social work activities
Open in API
Filings indexed 1,098 across all filing types
Latest filing 2019-12-30 Regulatory Filings
Country IN India
Listing BSE.NS LALPATHLAB

About Dr. Lal Pathlabs Limited

https://www.lalpathlabs.com/

Dr. Lal Pathlabs Limited is a provider of diagnostic and related healthcare tests and services. The company offers a comprehensive range of clinical laboratory tests and profiles used for prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases. Its service portfolio encompasses pathology, including biochemistry, hematology, clinical pathology, histopathology, and molecular diagnostics, as well as radiology services such as X-ray, ultrasound, and CT scans. The organization operates an extensive network of laboratories, patient service centers, and pick-up points, utilizing advanced automated systems and standardized processes. Key offerings include specialized wellness packages and home sample collection. The company maintains high quality standards through international and national accreditations, serving a diverse patient base and healthcare providers with a focus on accuracy and timely reporting.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated December 30, 2019, addressed to stock exchanges regarding the intimation of analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events and information. The content is about scheduling and informing about investor meetings, with no financial data, report, or detailed presentation included. The document length is only 1786 characters, indicating it is a brief announcement rather than a full report or transcript. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2019-12-30 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a notice regarding the closure of the trading window in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. It informs the stock exchanges about the trading window closure period around the announcement of financial results for the quarter ended December 31, 2019. The document is short (1632 characters) and serves as an announcement or intimation rather than containing any financial data or detailed report. It does not contain financial statements, management discussion, or audit information. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2019-12-26 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated December 20, 2019, addressed to stock exchanges regarding the schedule of analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure obligations. The content is an intimation or announcement about upcoming meetings, not a financial report or detailed presentation. The document length is only 1788 characters, indicating it is brief and informational. There is no financial data, no detailed report, no voting results, no management changes, or other report types. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and disclosures that do not fit other specific categories.
2019-12-20 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding the schedule of analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure obligations. The content is about announcing upcoming investor meetings, including dates, participants, and meeting types. There is no financial data, report, or detailed presentation included. The document is short (1759 characters) and serves as an announcement rather than a report or transcript. Therefore, it fits best under the category of Investor Presentation (IP) as it relates to investor meetings and presentations, but since it only announces the schedule and does not contain the presentation itself, it is more appropriate to classify it as a Regulatory Filing (RNS) because it is a general regulatory announcement about investor meetings without substantive financial or presentation content.
2019-12-19 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice (2022 characters) addressed to stock exchanges regarding the schedule of analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is about informing the exchange of upcoming investor meetings, not a financial report or earnings release. It does not contain financial data, results, or detailed presentations. It is an announcement of meetings with investors, which fits best under Regulatory Filings (RNS) as a general regulatory announcement and disclosure. The document is not a report, transcript, or financial statement, and is too short and specific to be any other category.
2019-12-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated December 9, 2019, addressed to stock exchanges regarding the schedule of analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure obligations. The content is an announcement of upcoming meetings with investors and analysts, explicitly stating no unpublished price sensitive information will be shared. The document is brief (2121 characters) and does not contain any financial data, results, or detailed reports. It is not a financial report, earnings release, or management discussion. It is an update related to investor relations and regulatory disclosure. Given the nature and length, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2019-12-09 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.